We know that they only need $4 or 5 m to kick off more relevant activity that is relevant to the assets, these are further proof of concept studies etc. so all they need is a small interested investor willing to plug in cash. Ph3 was planned for oral nadolol, but was put on ice. Ph3 is serious money (because of large study and FDA regs), .
Seems there is a 'low funder' and 'high funder' path that the company could take. Or a no funder path (Eeeeeek).
NIH will keep its study outcomes and progress them? why would NIH invest in that and then just let it be. Its just too much work to completely go up in smoke. But i'm no expert.
Invion is funded to maybe June/July? 2-3 months away really.
No need for website anymore. Makes sense. Would have liked to see GC tweet something about restricted presence. Otherwise a bad look.
IVX Price at posting:
0.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)